Monari P, Farisoglio C, Calzavara Pinton P G
Department of Dermatology, University of Brescia, Azienda Spedali Civili, Brescia, Italy.
Dermatology. 2007;215(3):229-32. doi: 10.1159/000106580.
An association between Borrelia burgdorferi with primary cutaneous B-cell lymphoma (PCBCL) has long been suspected but just recently, thanks to a polymerase chain reaction technique, it had been possible to demonstrate B. burgdorferi-specific DNA in skin lesions of patients with different PCBCL subtypes. Locating cases of PCBCL that are related to B. burgdorferi infection could be really important for therapeutic implications; in fact, there are several reports of PCBCL responding to antibiotic therapy against B. burgdorferi. We report a case of B. burgdorferi-associated primary cutaneous marginal-zone B-cell lymphoma that, after specific antimicrobial therapy, did not show any clinical regression. We can conclude that additional studies are necessary in order to establish the use of antimicrobial therapy in B. burgdorferi-associated PCBCL.
长期以来,人们一直怀疑伯氏疏螺旋体与原发性皮肤B细胞淋巴瘤(PCBCL)之间存在关联,但直到最近,由于聚合酶链反应技术,才有可能在不同PCBCL亚型患者的皮肤病变中检测到伯氏疏螺旋体特异性DNA。确定与伯氏疏螺旋体感染相关的PCBCL病例对于治疗意义可能非常重要;事实上,有几篇关于PCBCL对抗伯氏疏螺旋体抗生素治疗有反应的报道。我们报告了一例伯氏疏螺旋体相关的原发性皮肤边缘区B细胞淋巴瘤病例,在进行特异性抗菌治疗后,未出现任何临床缓解。我们可以得出结论,有必要进行更多研究,以确定抗菌治疗在伯氏疏螺旋体相关PCBCL中的应用。